Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR2 | P41597 | 18/20 | 0.70 |
| ▸ | CYP2D6 | P10635 | 6/20 | 0.62 |
| ▸ | KCNH2 | Q12809 | 5/20 | 0.62 |
| ▸ | CCR5 | P51681 | 1/20 | 0.60 |
| ▸ | GPR139 | Q6DWJ6 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5483485 | 1.00 | CCR2 (0.70) | CCR2CYP2D6KCNH2CCR5GPR139 | |
| SCHEMBL5033544 | 0.86 | CCR2 (0.55) | CCR2CYP2D6KCNH2CCR5GPR139 | |
| SCHEMBL5033706 | 0.83 | CCR2 (1.00) | CCR2CYP2D6KCNH2CCR5 | |
| SCHEMBL5033710 | 0.83 | CCR2 (1.00) | CCR2CYP2D6KCNH2CCR5 | |
| SCHEMBL5029122 | 0.80 | CCR2 (0.76) | CCR2CYP2D6KCNH2CCR5 | |
| SCHEMBL5029387 | 0.79 | CCR2 (0.75) | CCR2CYP2D6KCNH2CCR5 | |
| SCHEMBL5029125 | 0.79 | CCR2 (0.75) | CCR2CYP2D6KCNH2CCR5 | |
| SCHEMBL5029120 | 0.79 | CCR2 (0.75) | CCR2CYP2D6KCNH2CCR5 | |
| SCHEMBL5029393 | 0.79 | CCR2 (0.75) | CCR2CYP2D6KCNH2CCR5 | |
| SCHEMBL5033657 | 0.78 | CCR2 (0.80) | CCR2CYP2D6KCNH2CCR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1656138-A4 | SUBSTITUTED CYCLOALKYAMINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | BRISTOL MYERS SQUIBB CO (US) | 2007-04-18 | — | — | EP | disclosed |
| EP-1656138-A2 | SUBSTITUTED CYCLOALKYAMINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | Bristol-Myers Squibb Company (US) | 2006-05-17 | — | — | EP | disclosed |
| WO-2005020899-A2 | SUBSTITUTED CYCLOALKYAMINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | BRISTOL-MYERS SQUIBB COMPANY (US) | 2005-03-10 | — | — | WO | disclosed |